Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
GEMMABio Logo
GEMMABio Growth Score
70
CB Rank
23502
Heat Score
60
GEMMABio is a therapeutics company that develops gene therapies for individuals living with rare diseases.
Founded
obfuscation
PrivateSeed Philadelphia, Pennsylvania, United States51-100 gemmabiotx.com
Biotechnology
Health Care
Therapeutics
Overview

GEMMABio
Total Funding
obfuscation
Growth Score
70
Heat Score
60

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score70
-9 pts
in past quarter
Heat Score 60
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About GEMMABio

CB Rank
23502
GEMMABio is a therapeutics company that develops gene therapies for individuals living with rare diseases.
Founded
obfuscation
PrivateSeed Philadelphia, Pennsylvania, United States51-100 gemmabiotx.com
Biotechnology
Health Care
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name GEMMABio
Operating Status Active
Company Type For Profit
Founders  James Wilson
About the Company
GEMMABio is a therapeutics company focused on developing gene therapies for individuals living with rare diseases, aiming to enhance global access to advanced treatments. he company's mission includes improving research speed and global accessibility of life-changing therapies for patients in need.
Phone Number +1 445 201 3569
Contact Email info@gemmabiotx.com
Predictions & Insights

Growth Insight

See this Growth Insight
GEMMABio is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Gene Therapy Research
GEMMABio focuses on advancing gene therapy research, particularly for rare diseases, by developing and delivering therapeutics globally.
AAV-Based Gene Therapies
GEMMABio utilizes adeno-associated viruses (AAV) as vectors for gene transfer, with several FDA-approved therapies and numerous active programs.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - GEMMABio Logo
Seed Round - GEMMABio
4
obfuscation
Bioluminescence Ventures, Double Point Ventures, Earlybird Venture CapitalSeed
obfuscation
Seed Round - GEMMABio Logo
Seed Round - GEMMABio
4
obfuscation
Bioluminescence Ventures, Double Point Ventures, Earlybird Venture CapitalSeed
obfuscation
Seed Round - GEMMABio Logo
Seed Round - GEMMABio
4
obfuscation
Bioluminescence Ventures, Double Point Ventures, Earlybird Venture CapitalSeed
obfuscation
Seed Round - GEMMABio Logo
Seed Round - GEMMABio
4
obfuscation
Bioluminescence Ventures, Double Point Ventures, Earlybird Venture CapitalSeed
obfuscation
Seed Round - GEMMABio Logo
Seed Round - GEMMABio
4
obfuscation
Bioluminescence Ventures, Double Point Ventures, Earlybird Venture CapitalSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - GEMMABio Logo
Seed Round - GEMMABio
4
obfuscation
Bioluminescence Ventures, Double Point Ventures, Earlybird Venture CapitalSeed
obfuscation
Seed Round - GEMMABio Logo
Seed Round - GEMMABio
4
obfuscation
Bioluminescence Ventures, Double Point Ventures, Earlybird Venture CapitalSeed
obfuscation
Seed Round - GEMMABio Logo
Seed Round - GEMMABio
4
obfuscation
Bioluminescence Ventures, Double Point Ventures, Earlybird Venture CapitalSeed
obfuscation
Seed Round - GEMMABio Logo
Seed Round - GEMMABio
4
obfuscation
Bioluminescence Ventures, Double Point Ventures, Earlybird Venture CapitalSeed
obfuscation
Seed Round - GEMMABio Logo
Seed Round - GEMMABio
4
obfuscation
Bioluminescence Ventures, Double Point Ventures, Earlybird Venture CapitalSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 1

Employee Profiles

News

News and Press

News•Mar 3, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 26, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 24, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 6, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

35
-96.67%
 in past month

IT Spend

$831.7KThis year, GEMMABio is projected to spend $831.7K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Business Insider Logo
Business Insider
72
WordPress Logo
WordPress
72

Active Website Tech Count

2GEMMABio is actively using 2 technologies for its website, according to BuiltWith. These include SSL by Default and  CommonCrawl Top 10m.
Sub-Organizations
Frequently Asked Questions

Where is GEMMABio's headquarters? GEMMABio is located in Philadelphia, Pennsylvania, United States.Who invested in GEMMABio? GEMMABio has 4 investors including Earlybird Venture Capital and  Savanne Life Sciences.When was the last funding round for GEMMABio? GEMMABio closed its last funding round on
obfuscation
from a Seed round.Who are GEMMABio's competitors? Alternatives and possible competitors to GEMMABio may include Asklepios BioPharmaceutical, Solid Biosciences, and  Ultragenyx Pharmaceutical.How much funding has GEMMABio raised to date? GEMMABio has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|